Revance Therapeutics
Revance Therapeutics develops and commercializes aesthetic and therapeutic products, including the prescription botulinum toxin injectable DAXXIFY. Founded in 1999 as Essentia Biosystems and headquartered in Nashville, Tennessee, it was acquired by Crown Laboratories in February 2025; the combined group operates under the Revance brand.
Key facts
| Also Known As | Revance |
|---|---|
| CAGE Code | 6PA56 |
| Legal Name | Revance Therapeutics, Inc. |
| Company Operating Status | Acquired |
| Full Address | 1222 Demonbreun St 20th Floor Nashville, TN 37203 |
| Wellfound ID | revance-therapeutics |
Contact details
Email and phone for Revance Therapeutics are available to signed-in members of CliffBio.
Sign in to view